Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer

ConditionBradycardia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedtronic Cardiac Rhythm and Heart Failure

About this trial

The purpose of this study is to collect and compare the heart's electrical activity data measured by the novel Conduction System Pacing (CSP) Display Research System with data measured via 12 lead electrocardiogram (ECG) from a commercially available, standard of care electro-physiology (EP) monitoring and recording device during the pacemaker implantation. Participants receiving a routine de-novo implantation of a pacemaker for left bundle branch area pacing (LBBAP) will undergo the CSP Display System protocol during the implant procedure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject is at least 18 years of age

Subject is willing and able to provide written informed consent

Subject is willing and able to comply with the protocol

Subject meets eligibility for de-novo implant of a pacemaker (single or dual chamber) with left bundle branch area pacing (LBBAP) therapy

Disqualifiers

Subject is not available to comply with visit schedule

Pregnant or breastfeeding woman (pregnancy test required for woman of child-bearing potential and who are not on a reliable form of birth regulation method or abstinence)

Subject is currently enrolled or planning to enroll in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study.

Subject meets any exclusion criteria required by local law

Trial population

The target population for the CSP Display study will include subjects who are indicated to receive a de-novo pacemaker implant (single or dual chamber) with left bundle branch area pacing (LBBAP) based on market approved indications.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • CSP Display research system

    Device

    Research system used during pacemaker implantation to visualize surface electrocardiogram data and automatically measure left ventricular activation time

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Patients receiving a clinically indicated single- or dual-chamber pacemaker implantation1 intervention

Trial outcomes

Primary outcomes

1

Left Ventricular Activation Time (LVAT)

LVAT measured using the CSP Display Research System and a commercial electrophysiology recording system

Time frame
During pacemaker implant procedure

Secondary outcomes

1

Surface ECG V1 morphology

V1 morphology observed using the CSP Display Research System and a commercial electrophysiology recording system.

Time frame
During pacemaker implant procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.